Clinical Trial Detail

NCT ID NCT01962792
Title Study of the Bruton's Tyrosine Kinase Inhibitor in Combination With Carfilzomib (Kyprolis), in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Pharmacyclics
Indications

multiple myeloma

Therapies

Carfilzomib + Ibrutinib

Dexamethasone

Age Groups: adult

No variant requirements are available.